Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Investigating the Validity of the Minimal Disease Activity State for Patients with Rheumatoid Arthritis Treated with Abatacept

GEORGE A. WELLS, MAARTEN BOERS, TRACY LI and PETER S. TUGWELL
The Journal of Rheumatology February 2009, 36 (2) 260-265; DOI: https://doi.org/10.3899/jrheum.080059
GEORGE A. WELLS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gawells@ottawaheart.ca
MAARTEN BOERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TRACY LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER S. TUGWELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 36 no. 2 260-265
DOI 
https://doi.org/10.3899/jrheum.080059
PubMed 
19208559

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • September 9, 2008
  • Published online February 9, 2009.

Article Versions

  • Latest version (January 22, 2009 - 23:15).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009

Author Information

  1. GEORGE A. WELLS,
  2. MAARTEN BOERS,
  3. TRACY LI and
  4. PETER S. TUGWELL
  1. From the Department of Epidemiology and Community Medicine and the Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada; Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands; and Bristol-Myers Squibb, Princeton, New Jersey, USA.
  2. G.A. Wells, PhD, Department of Epidemiology and Community Medicine, University of Ottawa; M. Boers, MSc, MD, PhD, Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre; T. Li, PhD, Bristol-Myers Squibb; P.S. Tugwell, MD, MSc, Institute of Population Health, University of Ottawa
  1. Address reprint requests to Prof. G.A. Wells, Department of Epidemiology and Community Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario KIH 8M5, Canada. E-mail: gawells{at}ottawaheart.ca

Article usage

Article usage: January 2009 to April 2022

AbstractFullPdf
Jan 200992011
Feb 20099381050
Mar 20096611435
Apr 20091911418
May 20091401019
Jun 20097986
Jul 20096845
Aug 200970510
Sep 20096815
Oct 20096211
Nov 20095367
Dec 20094264
Jan 20106133
Feb 20105705
Mar 20105577
Apr 20103211
May 20103926
Jun 201023119
Jul 20102000
Aug 20103234
Sep 20102311
Oct 20104011
Nov 20102644
Dec 20102414
Jan 20113222
Feb 20112110
Mar 20112815
Apr 20111924
May 20113445
Jun 20112332
Jul 20111712
Aug 20113014
Sep 20112522
Oct 20111900
Nov 20112311
Dec 20111421
Jan 20121501
Feb 20122112
Mar 20122324
Apr 2012721
May 20122043
Jun 20121210
Jul 20122113
Aug 2012900
Sep 20122311
Oct 20121102
Nov 2012943
Dec 20121300
Jan 20137212
Feb 20131611
Mar 20131923
Apr 20132023
May 20131821
Jun 2013610
Jul 20131311
Aug 2013533
Sep 20131502
Oct 2013600
Nov 2013810
Dec 20131101
Jan 20141501
Feb 2014811
Mar 20141910
Apr 20141900
May 20141210
Jun 20141544
Jul 2014200
Aug 2014500
Sep 20141001
Oct 20141312
Nov 2014910
Dec 20141802
Jan 2015601
Feb 2015500
Mar 20151323
Apr 20151501
May 20151222
Jun 2015710
Jul 2015311
Aug 2015511
Sep 2015600
Oct 2015510
Nov 2015200
Dec 2015600
Jan 20161100
Feb 20161000
Mar 2016320
Apr 2016700
May 2016401
Jun 2016312
Jul 20161300
Aug 2016912
Sep 2016900
Oct 20161023
Nov 20161400
Dec 20162400
Jan 20171400
Feb 2017600
Mar 2017801
Apr 2017911
May 20172100
Jun 20171800
Jul 20171921
Aug 20171700
Sep 20172563
Oct 20172000
Nov 20171832
Dec 20171500
Jan 20181600
Feb 20181100
Mar 20181800
Apr 20181811
May 20181400
Jun 20181701
Jul 20181910
Aug 2018510
Sep 20181300
Oct 2018900
Nov 20182000
Dec 20182011
Jan 2019800
Feb 2019700
Mar 2019900
Apr 2019310
May 2019302
Jun 2019611
Jul 2019400
Aug 2019611
Sep 2019400
Oct 20191411
Nov 20191400
Dec 20191000
Jan 2020720
Feb 2020171
Mar 2020120
Apr 20200581
May 2020251
Jun 2020063
Jul 20206913
Aug 2020388
Sep 2020463
Oct 2020061
Nov 2020284
Dec 20203102
Jan 2021542
Feb 20217153
Mar 20212126
Apr 20213101
May 20217556
Jun 20210181
Jul 2021040
Aug 2021169
Sep 20211101
Oct 2021186
Nov 2021111
Dec 2021686
Jan 2022175
Feb 2022252
Mar 20221102
Apr 2022191

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 2
1 Feb 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Investigating the Validity of the Minimal Disease Activity State for Patients with Rheumatoid Arthritis Treated with Abatacept
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Investigating the Validity of the Minimal Disease Activity State for Patients with Rheumatoid Arthritis Treated with Abatacept
GEORGE A. WELLS, MAARTEN BOERS, TRACY LI, PETER S. TUGWELL
The Journal of Rheumatology Feb 2009, 36 (2) 260-265; DOI: 10.3899/jrheum.080059

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Investigating the Validity of the Minimal Disease Activity State for Patients with Rheumatoid Arthritis Treated with Abatacept
GEORGE A. WELLS, MAARTEN BOERS, TRACY LI, PETER S. TUGWELL
The Journal of Rheumatology Feb 2009, 36 (2) 260-265; DOI: 10.3899/jrheum.080059
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire